With increasing information overload and packed work schedules, staying up-to-date on the newest oncologic advances is harder than ever. But take heart! The QuadShot is freshly brewed in your inbox four mornings each week so you can quickly down and digest the day's most pertinent cancer news.
Buy your Cologuard shares: Because at-home colon cancer screening boosted by pandemic lockdowns may be here to stay. | Jaklevic, JAMA 2021